SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Roos Jansåker Ann Marie)
 

Search: WFRF:(Roos Jansåker Ann Marie) > Short-term effects ...

Short-term effects of an anti-inflammatory treatment on clinical parameters and serum levels of C-reactive protein and proinflammatory cytokines in subjects with periodontitis

Renvert, Stefan, 1951- (author)
Högskolan Kristianstad,Sektionen för hälsa och samhälle
Lindahl, Christel (author)
Högskolan Kristianstad,Sektionen för hälsa och samhälle
Roos-Jansaker, Ann-Marie (author)
Department of Periodontology, Public Dental Health Service, Kristianstad
show more...
Lessem, Jan (author)
CombinatoRx, USA
Jansåker, Ann-Marie Roos (author)
show less...
 (creator_code:org_t)
AMER ACAD PERIODONTOLOGY, 2009
2009
English.
In: Journal of Periodontology. - : AMER ACAD PERIODONTOLOGY. - 0022-3492 .- 1943-3670. - 0022-3492 ; 80:6, s. 892-900
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Background: Periodontal disease is the most common multifactorial disease, afflicting a very large proportion of the adult population. Periodontal disease secondarily causes increases in the serum levels of C-reactive protein (CRP) and other markers of inflammation. An increased level of CRP reflects an increased risk for cardiovascular disease. The aim of the current randomized clinical trial was to evaluate the short-term effect of a combination of dipyridamole and prednisolone (CRx-102) on the levels of high-sensitivity (hs)-CRP, proinflammatory markers in blood, and clinical signs of periodontal disease. Methods: Fifty-seven patients with >= 10 pockets with probing depths >= 5 mm were randomized into two groups in this masked single-center placebo-controlled study: CRx-102 (n = 28) and placebo (n = 29). hs-CRP levels, inflammatory markers (interleukin [IL]-6, -1 beta, -8, and -12, tumor necrosis factor-alpha, and interferon-gamma [IFN-gamma]), bleeding on probing (BOP), and changes in probing depths were evaluated. The subjects received mechanical non-surgical therapy after 42 days, and the study was completed after 49 days. Results: At day 42, the differences in the hs-CRP, IFN-gamma, and IL-6 levels between the two groups were statistically significant (P<0.05), whereas no difference was found for the other inflammatory markers. There was no change in probing depth or BOP between the two groups. Conclusion: The administration of CRx-102 resulted in significant decreases in hs-CRP, IFN-gamma, and IL-6, but it did not significantly change BOP or probing depths.

Subject headings

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Dentistry (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Odontologi (hsv//swe)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Keyword

Anti-inflammatory agents
C-reactive protein
cytokines
periodontal
disease
DENSITY-LIPOPROTEIN CHOLESTEROL
ACUTE MYOCARDIAL-INFARCTION
CORONARY-HEART-DISEASE
CARDIOVASCULAR-DISEASE
RISK-FACTORS
SYSTEMIC
INFLAMMATION
ADULT PERIODONTITIS
CREVICULAR FLUID
INFECTION
THERAPY
ODONTOLOGY
ODONTOLOGI
periodontal disease

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view